Dive into the archives.
- Open Source Drug Discovery. A feasible business model?
Open Source Drug Discovery. A feasible business model? Jagadeesh Napa (Assistant Editor of Pharma Focus Asia) has a nice assay on Open Source Drug Discovery and is feasibility as a business model. We are glad that Jagadeesh has named TDI as one of the “major open source initiatives”.
- 2008 Target Competition for Neglected Diseases (UC Berkeley)
2008 Target Competition for Neglected Diseases (UC Berkeley) As part of their upcoming symposium, Infection & Host Response (Dec. 12, 2008 at UC Berkeley, http://cend.berkeley.edu), the UC Berkeley Center for Emerging and Neglected Diseases is sponsoring a Target Competition in which the winner will receive a screen of up to 100,000 molecules in the QB3 Small Molecule Discovery Center (SMDC).
- TDI kernel. Second take.
We introduce our new TDI Kernel v1.0 to the public domain. Open source drug discovery has so far remained elusive with few exceptions. We argue that the stumbling block has been the absence of a critical mass of preexisting work that volunteers can improve through a series of granular contributions. Historically, open source software collaborations have [...]
- New look for the tropicaldisease.org
Making our new web site public. The Tropical Disease Initiative has a new web site look. We have move our content management to WordPress, which will help us to tell you better what is happening with our initiative. Enjoy!
- TDI Matters!!
Aug. 8th. 2006 TDI is getting recognized… Mauer and Sali are in the list of 50 people who matter.
- Updates at TSL
Aug. 8th. 2006 Ginger Taylor of the TSL has updated us with all new things that are happening at The synaptic Leap.
- Schisto open-research community
Jan. 1st, 2006 TDI and TSL have initiated a Schisto open-research community. Have a look here!.
- The Synaptic Leap
Nov. 1st, 2005 TDI has partnership with The Synaptic Leap, a new organization dedicated towards providing a network of online communities that connect and empower scientific and medical researchers to conduct open source style research. Our first pilot project will aim to a gene polling for target selection in malaria structural genomics.